SmallCaps
ASX:PNVHealth Care Equipment & ServicesHealth Care SuppliesLive

Polynovo Ltd

PolyNovo Limited is an Australia-based medical technology company.

$0.950 ⁠$0.010 (1.04%)AUD · Open
-23.6%52-week return
Day Range
$0.945$0.975
52 Week Range
$0.000$0.995
Volume
889.30K
Avg Volume (10D)
2.50M
Market Cap
$656.30M
P/E Ratio
94.54
The company

The business

What Polynovo Ltd does

PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.

Incorporated
AUS
Public since
1998-11-26
Employees
301
Shareholders
18,734
Advertisement

Small Caps Research

Independent ASX small-cap coverage

No research on Polynovo Ltd yet

We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise PNV based on demand.

Share price & key data

Share price

OHLC · volume · moving averages
$0.950-$0.005 (-0.52%)over 6M
Hi$1.295Lo$0.000
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today
Open
$0.975
Prev Close
$0.960
Day High
$0.975
Day Low
$0.945
52wk High
$0.995
52wk Low
$0.000

Valuation

Multiples
Market Cap
$656.30M
Shares Out
690.84M
P/E (Annual)
94.54
P/E (TTM)
94.63
Price/Book
7.66

Trading Activity

Volume & book
Volume
889.30K
Value Traded
$847.81K
Bid
$0.950 × 9,802
Ask
$0.955 × 42,952
Avg Vol 10D
2.50M

Performance

Total return
1 Day
+0.00%
5 Day
-5.19%
13 Week
-9.05%
52 Week
-23.57%
YTD
-18.29%
Peers & news

Latest news

From the Small Caps desk
nib draws Medibank customers, Brickworks posts record profit and PolyNovo announces capital raise
ASX 200

nib draws Medibank customers, Brickworks posts record profit and PolyNovo announces capital raise

As Medibank (ASX: MPL) clients continue to fear for the safety of their data after the October cyber-attack, rival insurer nib Holdings (ASX: NHF) has confirmed some customers have made the switch over to its service. nib saw a 4.7% rise in policyholder growth from July to the end of October, which helped drive a […]

Fortescue invests in German green hydrogen project, PolyNovo achieves record quarter and Ampol partners with Hyundai
ASX 200

Fortescue invests in German green hydrogen project, PolyNovo achieves record quarter and Ampol partners with Hyundai

Fortescue Metals Group (ASX: FMG) has announced its green division, Fortescue Future Industries (FFI), has entered into a global strategic collaboration with energy infrastructure developer Tree Energy Solutions (TES) to execute a “world-leading” hydrogen project in Germany. As per the agreement, FFI’s subsidiary Netherlands Fortescue Future Industries will invest €30 million (A$46 million) to become […]

Westpac cuts lending to coal, oil and gas companies, Rio Tinto strikes landmark deal and PolyNovo appoints CEO
ASX 200

Westpac cuts lending to coal, oil and gas companies, Rio Tinto strikes landmark deal and PolyNovo appoints CEO

Australian banking giant Westpac (ASX: WBC) has announced plans to cut its lending to coal, oil and gas companies by nearly a quarter by 2030 in an effort to cut emissions. The move follows National Australia Bank’s (ASX: NAB) intentions to implement a $2.4 billion cap on lending to oil and gas companies and the […]

PolyNovo posts record US quarterly sales, secures debt facility for Melbourne factory expansion
Biotechnology

PolyNovo posts record US quarterly sales, secures debt facility for Melbourne factory expansion

Australian medical device company PolyNovo (ASX: PNV) has posted record US sales for the March 2020 quarter, validating an earlier claim that the coronavirus pandemic would not have any material impact on its business. The company’s sales for the quarter were $4.49 million, reflecting a 166% increase on the $1.69 million recorded in the previous corresponding period, […]

Looking for charts & signals? See the tab.

◆ FREE MEMBER ACCESS

Unlock the full research library - free.

Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.

Full broker research library
Complete CEO interview archive
IPO calendar and alerts
New research alerts
Mobile notifications
Members-only market wraps
◆ Free account
Start free
No credit card · Takes 30 seconds · 200,000+ members
Unlock free access →
Continue with Google or email through our secure Auth0 signup.